Assessment of a 6-arylaminobenzamide lead derivative as a potential core scaffold for S1P5 positron emission tomography radiotracer development
Robert Shaw(University of Edinburgh), Adriana Tavares(The Queen's Medical Research Institute), Holly McErlain(University of Glasgow), Timaeus E. F. Morgan(University of Glasgow), Carlos J. Alcaide‐Corral(The Queen's Medical Research Institute), Adam Waldman(Royal Society of Edinburgh), Andrew Sutherland(University of Glasgow), David Y. Lewis, Dmitry A. Soloviev(University of Glasgow)
Cited by 1
Related Papers
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
Fasting biases brain reward systems towards high‐calorie foods
|European Journal of Neuroscience|2009|355
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding
|Gut|2013|287
Conventional MRI evaluation of gliomas
|British Journal of Radiology|2011|245